Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 3581–3600 of 17,529 recalls

March 23, 2022· Drug Depot, Inc., dba APS Pharmacy

Recalled Item: GONADORELIN (5ML) 0.2 MG/ML INJECTABLE

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 23, 2022· Drug Depot, Inc., dba APS Pharmacy

Recalled Item: TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 23, 2022· Drug Depot, Inc., dba APS Pharmacy

Recalled Item: TESTOSTERONE CYPIONATE/PROPIONATE *SES* Oil (10 ML) 160MG/20MG/ML Injectable

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 23, 2022· Dr. Reddy's Laboratories, Inc.

Recalled Item: Lansoprazole Delayed-Release Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 23, 2022· Drug Depot, Inc., dba APS Pharmacy

Recalled Item: TESTOSTERONE CYPIONATE *GS* (2 mL) 80 MG/ML Injectable

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 23, 2022· Drug Depot, Inc., dba APS Pharmacy

Recalled Item: TESTOSTERONE CYPIONATE *GS* Oil 200 MG/ML Injectable

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 23, 2022· Dr. Reddy's Laboratories, Inc.

Recalled Item: Lansoprazole Delayed-Release Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 23, 2022· Drug Depot, Inc., dba APS Pharmacy

Recalled Item: TESTOSTERONE CYPIONATE/ANASTROZOLE *GS* OIL 200MG/1MG/ML Injectable

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 23, 2022· Drug Depot, Inc., dba APS Pharmacy

Recalled Item: (CA) GONADORELIN (4ML) 0.2 MG/ML INJECTABLE

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 21, 2022· Adamis Pharmaceuticals Corporation

Recalled Item: SYMJEPI (epinephrine injection

The Issue: Defective Delivery System: Potential clogging of the needle

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 21, 2022· Pfizer Inc.

Recalled Item: Accuretic (quinapril HCl/hydrochlorothiazide) Tablets

The Issue: CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 21, 2022· Adamis Pharmaceuticals Corporation

Recalled Item: SYMJEPI (epinephrine injection

The Issue: Defective Delivery System: Potential clogging of the needle

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 21, 2022· Pfizer Inc.

Recalled Item: quinapril and hydrochlorothiazide tablets

The Issue: CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 21, 2022· Sandoz, Inc

Recalled Item: Orphenadrine Citrate Extended-Release Tablets

The Issue: CGMP Deviations:Nitrosamine impurity (NMOA) above the acceptable daily

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 21, 2022· Pfizer Inc.

Recalled Item: quinapril HCl/hydrochlorothiazide tablets

The Issue: CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 21, 2022· Pfizer Inc.

Recalled Item: Accuretic (quinapril HCl/hydrochlorothiazide) tablets

The Issue: CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 21, 2022· Revive Personal Products Company

Recalled Item: The Natural Dentist Healthy Breath Antiseptic Rinse

The Issue: Labeling; Label mix-up and Wrong Bar Code; back

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 21, 2022· Pfizer Inc.

Recalled Item: Accuretic (quinapril HCl/hydrochlorothiazide) Tablets

The Issue: CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 21, 2022· Pfizer Inc.

Recalled Item: quinapril HCl/hydrochlorothiazide tablets

The Issue: CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 21, 2022· Pfizer Inc.

Recalled Item: Accuretic (quinapril HCl/hydrochlorothiazide) Tablets

The Issue: CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund